26
Participants
Start Date
September 30, 2006
Study Completion Date
April 30, 2007
FP9-PP (FP9 polyprotein)
MVA-PP (Modified Virus Ankara polyprotein)
Imperial College, University of London, London
Centre for Clinical Vaccinology & Tropical Medicine, University of Oxford, Oxford
University of Oxford
OTHER
Wellcome Trust
OTHER
Walter Reed Army Institute of Research (WRAIR)
FED
European Vaccine Initiative
OTHER